Frontlight ResearchEarly access
CompletedNo phase
DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients
Key facts
- Who runs it
- ITALO EUGENIO SOUZA GADELHA DE ABREU
- Where
- Brazil1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 59 people enrolled
- Started
- 20 Jan 2025
- Ended
- 10 Oct 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- DOACT algorithm
- No algorithm
- LLM-based tools
- Record updated
- 18 December 2025
Who can take part
- Age
- 18 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Physicians with residency training in Vascular Surgery or official Board Certification in Vascular Surgery
- Currently practicing clinical and/or surgical vascular care in Brazil
- Completed the informed consent process (TCLE) and voluntarily agreed to participate
Who cannot take part
- Physicians without formal Vascular Surgery residency and without Board Certification
- Physicians not performing vascular clinical or surgical care (e.g., exclusively administrative, academic, or non-assistance roles)
- Capable of producing complete, text-based clinical answers relevant to vascular surgery decision-making
- Less than 1 year of professional experience after medical school graduation
- Did not sign or did not fully complete the TCLE; Large Language Models (LLMs)
- Inclusion Criteria
- Free-access LLMs available to the public at the time of data collection
- All responses generated using the same standardized prompt
- Paid or subscription-based LLMs
- LLMs requiring institutional licenses, restricted access, or proprietary tokens
- Models unable to generate full responses to the standardized prompt
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Study using a decision algorithm for the application of an oral anticoagulant calculator in vascular diseases, aimed at validating a clinical decision-support tool for conditions such as deep vein thrombosis, superficial thrombophlebitis, and pulmonary thromboembolism.
The 3 groups in the trial
- DOACT algorithmTreatment being tested
Use of DOACT algorithm (Dose-Oriented Anticoagulant Calculator for Evidence-Based Decision Tool) to recommend appropriate oral anticoagulant regimens.
- No algorithmPlacebo, for comparison
Standard clinical decision-making to recommend appropriate oral anticoagulant regimens.
- LLM-based toolsExisting treatment, for comparison
Use of large language model (LLM)-based tools to recommend appropriate oral anticoagulant regimens.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Performance of the DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients
- Record updated
- 18 December 2025